Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2672 of 5804
-
New imaging technique may reveal why prone positioning helps some ARDS patients
Knowledge-focused CompletedPatients with ARDS often suffer a gravity-dependent alveolar collapse, resulting in a reduction of tidal volume, residual alveolar excessive distension, and ventilator-related lung injury(VILI) induced by unreasonable ventilator setting.Prone ventilation (PPV) improves the gravit…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:27 UTC
-
New immune booster FL115 tested in patients with advanced cancers
Disease control CompletedFirst-in-Human, Phase I, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary antitumor activity of FL115 in patients with advanced solid tumors who have progressed or are intolerant to current standard-of-care…
Phase: PHASE1 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New wound pump shows promise for stubborn leg ulcers
Symptom relief TerminatedThis study intends to demonstrate the superiority of PICO treatment when applied up to 12 weeks, versus Standard of Care (SOC) in the treatment of hard to heal Venous Leg Ulcers (VLU) by community-based practitioners. The primary endpoint is the incidence of confirmed healed VLUs…
Phase: NA • Sponsor: Smith & Nephew, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Psoriasis drug shows promise for kids in Real-World study
Disease control OngoingMulticenter, non-interventional, cohort study in pediatric patients with moderate to severe plaque-type psoriasis. Retrospective data collection is planned at patients' inclusion.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug aims to ease Post-Surgery pain without opioids
Symptom relief CompletedMR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.
Phase: PHASE3 • Sponsor: Viatris Specialty LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New program aims to close cancer screening gaps for rural families
Disease control ENROLLING_BY_INVITATIONThis study aims to improve cancer prevention and surveillance adherence in patients with Hereditary Cancer Syndromes (HCS), particularly those living in rural areas. The study will evaluate whether enrolling HCS patients in a longitudinal clinical program with individualized care…
Phase: NA • Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New pill aims to tame dangerous immune storms from cancer therapy
Disease control Recruiting nowThis is an interventional study to evaluate the use of CTO1681 in preventing or reducing CAR T-cell-induced toxicities like cytokine release syndrome (CRS). This study will enroll adult patients with DLBCL who are scheduled to receive CD19-directed CAR T-cell therapy. The first …
Phase: PHASE1, PHASE2 • Sponsor: CytoAgents, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Kindness training boosts Well-Being in kids with ADHD
Symptom relief CompletedThe study aims to investigate the underlying mechanism between Attention Deficit/Hyperactivity Disorder traits (AD/HD traits) and psychological well-being through studying the role of perceived criticism, rejection sensitivity, self-compassion and growth mindset. It also aims to …
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Could this pill help veterans with PTSD finally sleep?
Symptom relief Recruiting nowThis is a preliminary randomized, double-blind, placebo-controlled trial comparing pimavanserin 34mg at bedtime vs. placebo for the treatment of insomnia associated with post-traumatic stress disorder.
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Engineered immune cells take on Hard-to-Treat gut cancers
Disease control TerminatedThis is a phase 1, single-arm, open-label, dose escalation and expansion study of LCAR-G08 in adult subjects with advanced gastrointestinal tumors expressing guanylyl cyclase C (GCC).
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Air purifiers may tame blood sugar spikes in prediabetes
Disease control CompletedThe purpose of this interventional sham-controlled pilot study is to study the effects of using portable air cleaners (PACs) in outpatient adults with prediabetes. The primary aims are to determine the effect PAC's have on glycemic variability and the concentrations of circulatin…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart pump therapy shows promise for long COVID sufferers
Symptom relief CompletedThe goal of this clinical trial is to learn whether enhanced external counterpulsation (EECP) therapy can improve cardiopulmonary function and symptoms in adults with long COVID. It will also evaluate the safety and feasibility of two different EECP treatment schedules. The main…
Phase: NA • Sponsor: National Defense Medical Center, Taiwan • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
VR training shows promise for Kids' eye misalignment
Disease control CompletedThis study evaluates the efficacy and safety of visual perceptual learning for improving stereopsis in intermittent exotropia. Half of participants will receive visual perceptual training using the Nu.T. The other half will not receive any training because there is no standard tr…
Phase: NA • Sponsor: Nunaps Inc • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
Could a bladder drug help POTS patients stop fainting?
Symptom relief CompletedThis is a pilot dose-finding study to test the hypothesis that mirabegron increases systolic blood pressure (BP), prevents syncope/presyncope, and improves the quality of life (QOL), functional capacity, chest pain, and overactive bladder (OAB) symptoms in patients with postural …
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Virtual reality offers new hope for phantom limb pain
Symptom relief Recruiting nowPhantom limb pain (PLP) is a significant and pervasive issue among upper limb amputees, severely impacting their quality of life. The literature delineating prevalence of upper versus lower limb amputations is limited, but the prevalence of total amputations in the United States …
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Brain zaps aim to ease Writer's cramp
Symptom relief OngoingThis study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal hand dystonia. Previous research demonstrated that individualized TMS improved dystonic behavior after one session. Building on t…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New pneumonia vaccine shows promise in large adult trial
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to learn about the safety and immune effects of a pneumococcal vaccine in adults. This vaccine can possibly provide protection against further pneumococcal disease. This study will happen in 4 stages: Stage 1 is seeking participants who are between 1…
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:06 UTC
-
New smart socket aims to get amputees moving again
Symptom relief OngoingThe study will test a new approach to the design and implementation of socket and liner technology in individuals who lost a lower limb secondary to diabetes mellitus type II (herein referred to as dysvascular amputees). The technology-based intervention will be combined with an …
Phase: PHASE2 • Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
RA treatment showdown: low activity vs. remission
Disease control OngoingThere is currently no cure for rheumatoid arthritis (RA), but many treatment options are available. The central aim of RA treatment is lowering disease activity. The proactive treatment strategy called treat to target (T2T) includes measuring disease activity, setting a target an…
Phase: NA • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Jun 26, 2026 15:30 UTC
-
Could a common ADHD drug help kids with severe obesity?
Disease control CompletedThis study will randomize children who have difficulty maintaining a healthy weight to one of two treatment groups: lifestyle therapy plus lisdexamfetamine or lifestyle therapy plus placebo.
Phase: EARLY_PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC